Arktek: Strengthening and Extending Vaccine Service
Immunizations have become one of the greatest success stories in modern medicine, yet roughly 1.5 million children still die each year from vaccine-preventable diseases. This is due in part to the sensitive nature of vaccines themselves, which spoil if they’re not kept at precise temperatures as they move from manufacturer to those who are depending on them.
Immunizations rates are lowest in rural areas, such as Sub-Saharan Africa, where poor infrastructure and unreliable power make reliable, life-saving vaccines hard to come by. Working with IV’s Global Good program – a collaborative effort between Bill Gates and Intellectual Ventures to address some of humanity’s toughest problems through the power of scientists and engineers at IV Lab set out to address this challenge by inventing and developing a passive vaccine storage device that can keep vaccines cold with no need for external energy.
Arktek™, our latest passive vaccine storage device, employs super insulation techniques similar to those used to store cryogenic fluids and protect spacecraft from extreme temperatures. Once stocked with ice, Arktek can keep vaccines at the appropriate temperature for a month or more.
Our commercial partner, AUCMA, is moving Arktek beyond manufacturing and into distribution in the communities with the lowest rates of vaccination. Based in China, AUCMA is the country’s largest refrigeration manufacturer and is a critical collaborator in our efforts to get a passive vaccine storage device to those who need it most.
Breakthroughs like these power our belief that invention is the driver of all progress. Learn more about Arktek here. Intellectual Ventures. A global inventions company.